Synergistic effects of nell-1 and BMP-2 on the osteogenic differentiation of myoblasts

Journal of Bone and Mineral Research

Volumn 22, Issue 6, 2007, Pages 918-930

  Cowan, Catherine M ^a,b   Jiang, Xinquan ^c   Hsu, Tiffany ^b   Soo, Chia ^d   Zhang, Beiji ^b   Wang, Joyce Z ^b   Kuroda, Shun'ichi ^e   Wu, Benjamin ^a,b   Zhang, Zhiyuan ^c   Zhang, Xinli ^b   Ting, Kang ^b,f  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e OSAKA UNIVERSITY   (Japan)

^f UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

BMP 2; C2C12; Muscle; Nell 1; Osteogenesis; Synergy

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEL LIKE MOLECULE 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE; BMP2 PROTEIN, MOUSE; BMPR1B PROTEIN, MOUSE; BMPR2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; HIGH MOBILITY GROUP PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NELL1 PROTEIN, RAT; NERVE PROTEIN; OSTEOPONTIN; SOX-9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; MALE; MESENCHYME CELL; MOUSE; MYOBLAST; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ADENOVIRUS; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; METABOLISM; OSTEOBLAST; PHYSIOLOGY; RAT; SKELETAL MUSCLE;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIGH MOBILITY GROUP PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, NUDE; MUSCLE, SKELETAL; MYOBLASTS; NERVE TISSUE PROTEINS; OSTEOBLASTS; OSTEOGENESIS; OSTEOPONTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34548216378     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.070312     Document Type: Article

References (43)

1. 1 Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G 1993 Expression of human bone morphogenetic proteins‐2 or −4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12: 871–880.
2. 2 Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa‐Sehara A, Suda T 1994 Bone morphogenetic protein‐2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755–1766.
3. 3 Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T 2002 Core‐binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31: 303–312.
4. 4 Derynck R, Zhang YE 2003 Smad‐dependent and Smad‐independent pathways in TGF‐beta family signalling. Nature 425: 577–584.
5. 5 Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT 2003 In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein‐2 in stimulating osteoblast differentiation. J Bone Miner Res 18: 705–715.
6. 6 Zhao M, Zhao Z, Koh JT, Jin T, Franceschi RT 2005 Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem 95: 1–16.
7. 7 Spinella‐Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman‐Roman S 2001 Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 114: 2085–2094.
8. 8 Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F 2004 Oxysterols regulate differentiation of mesenchymal stem cells: Pro‐bone and anti‐fat. J Bone Miner Res 19: 830–840.
9. 9 Yeh LC, Zavala MC, Lee JC 2006 C‐type natriuretic peptide enhances osteogenic protein‐1‐induced osteoblastic cell differentiation via Smad5 phosphorylation. J Cell Biochem 97: 494–500.
10. 10 Zhang X, Kuroda S, Carpenter D, Nishimura I, Soo C, Moats R, Iida K, Wisner E, Hu FY, Miao S, Beanes S, Dang C, Vastardis H, Longaker M, Tanizawa K, Kanayama N, Saito N, Ting K 2002 Craniosynostosis in transgenic mice overexpressing Nell‐1. J Clin Invest 110: 861–870.
11. 11 Ting K, Vastardis H, Mulliken JB, Soo C, Tieu A, Do H, Kwong E, Bertolami CN, Kawamoto H, Kuroda S, Longaker MT 1999 Human NELL‐1 expressed in unilateral coronal synostosis. J Bone Miner Res 14: 80–89.
12. 12 Watanabe TK, Katagiri T, Suzuki M, Shimizu F, Fujiwara T, Kanemoto N, Nakamura Y, Hirai Y, Maekawa H, Takahashi E 1996 Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF‐like repeats. Genomics 38: 273–276.
13. 13 Kuroda S, Oyasu M, Kawakami M, Kanayama N, Tanizawa K, Saito N, Abe T, Matsuhashi S, Ting K 1999 Biochemical characterization and expression analysis of neural thrombospondin‐1‐like proteins NELL1 and NELL2. Biochem Biophys Res Commun 265: 79–86.
14. 14 Desai J, Shannon ME, Johnson MD, Ruff DW, Hughes LA, Kerley MK, Carpenter DA, Johnson DK, Rinchik EM, Culiat CT 2006 Nell‐1 deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet 15: 1329–1341.
15. 15 Kuroda S, Tanizawa K 1999 Involvement of epidermal growth factor‐like domain of NELL proteins in the novel protein‐protein interaction with protein kinase C. Biochem Biophys Res Commun 265: 752–757.
16. 16 Zhang X, Carpenter D, Bokui N, Soo C, Miao S, Truong T, Wu B, Chen I, Vastardis H, Tanizawa K, Kuroda S, Ting K 2003 Overexpression of Nell‐1, a craniosynostosis‐associated gene, induces apoptosis in osteoblasts during craniofacial development. J Bone Miner Res 18: 2126–2134.
17. 17 Truong S, Zhang X, Pathmanathan D, Soo C, Ting K 2007 Craniosynostosis‐associated gene Nell‐1 is regulated by Runx2. J Bone Miner Res I22: 7–18.
18. 18 Cowan C, Cheng S, Ting K, Soo C, Walder B, Wu B, Kuroda S, Zhang X 2005 Nell‐1 induced bone formation within the distracted intermaxillary suture. Bone 38: 48–58.
19. 19 Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW 2001 SP600125, an anthrapyrazolone inhibitor of Jun N‐terminal kinase. Proc Natl Acad Sci USA 98: 13681–13686.
20. 20 Heid CA, Stevens J, Livak KJ, Williams PM 1996 Real time quantitative PCR. Genome Res 6: 986–994.
21. 21 Berger F, Lee YP, Loening AM, Chatziioannou A, Freedland SJ, Leahy R, Lieberman JR, Belldegrun AS, Sawyers CL, Gambhir SS 2002 Whole‐body skeletal imaging in mice utilizing microPET: Optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging 29: 1225–1236.
22. 22 Cowan C, Shi Y, Aalami O, Chou Y, Mari C, Thomas R, Quarto N, Contag C, Wu B, Longaker M 2004 Adipose‐derived adult stromal cells heal critical‐sized mouse calvarial defects. Nat Biotechnol 22: 560–567.
23. 23 Shi SR, Liu C, Balgley BM, Lee C, Taylor CR 2006 Protein extraction from formalin‐fixed, paraffin‐embedded tissue sections: Quality evaluation by mass spectrometry. J Histochem Cytochem 54: 739–743.
24. 24 Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC 2003 Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85: 1544–1552.
25. 25 Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI 2001 In vitro and in vivo studies of a bone morphogenetic protein‐2 expressing adenoviral vector. J Bone Joint Surg Am 83 (Suppl 1): S99–S104.
26. 26 Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S 1999 Expression of bone morphogenetic protein‐2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun 262: 739–743.
27. 27 Alden TD, Pittman DD, Hankins GR, Beres EJ, Engh JA, Das S, Hudson SB, Kerns KM, Kallmes DF, Helm GA 1999 In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 10: 2245–2253.
28. 28 Sonobe J, Okubo Y, Kaihara S, Miyatake S, Bessho K 2004 Osteoinduction by bone morphogenetic protein 2‐expressing adenoviral vector: Application of biomaterial to mask the host immune response. Hum Gene Ther 15: 659–668.
29. 29 Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS 2004 Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14: 1–41.
30. 30 Lee KS, Hong SH, Bae SC 2002 Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor‐beta and bone morphogenetic protein. Oncogene 21: 7156–7163.
31. 31 Zhang X, Cowan CM, Jiang X, Soo C, Miao S, Carpenter D, Wu B, Kuroda S, Ting K 2006 Nell‐1 induces acrania‐like cranioskeletal deformities during mouse embryonic development. Lab Invest 86: 633–644.
32. 32 Lenton KA, Nacamuli RP, Wan DC, Helms JA, Longaker MT 2005 Cranial suture biology. Curr Top Dev Biol 66: 287–328.
33. 33 Takahashi H, Goto N, Kojima Y, Tsuda Y, Morio Y, Muramatsu M, Fukuchi Y 2006 Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290: L450–L458.
34. 34 Takeda M, Otsuka F, Nakamura K, Inagaki K, Suzuki J, Miura D, Fujio H, Matsubara H, Date H, Ohe T, Makino H 2004 Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: Roles of BMP type IB receptor (activin receptor‐like kinase‐6) in the mitotic action. Endocrinology 145: 4344–4354.
35. 35 Izumi M, Fujio Y, Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Oshima Y, Nakaoka Y, Kishimoto T, Yamauchi‐Takihara K, Hirota H 2001 Bone morphogenetic protein‐2 inhibits serum deprivation‐induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol Chem 276: 31133–31141.
36. 36 Aihara K, Kuroda S, Kanayama N, Matsuyama S, Tanizawa K, Horie M 2003 A neuron‐specific EGF family protein, NELL2, promotes survival of neurons through mitogen‐activated protein kinases. Brain Res Mol Brain Res 116: 86–93.
37. 37 Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella‐Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman‐Roman S 2001 Activation of mitogen‐activated protein kinase cascades is involved in regulation of bone morphogenetic protein‐2‐induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28: 491–498.
38. 38 Hay E, Lemonnier J, Fromigue O, Marie PJ 2001 Bone morphogenetic protein‐2 promotes osteoblast apoptosis through a Smad‐independent, protein kinase C‐dependent signaling pathway. J Biol Chem 276: 29028–29036.
39. 39 Celil AB, Campbell PG 2005 BMP‐2 and IGF‐I mediate Osx expression in human mesenchymal stem cells via the MAPK and PKD signaling pathways. J Biol Chem 280: 31353–31359.
40. 40 Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger‐containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17–29.
41. 41 Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM 2003 BMP‐2‐induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309: 689–694.
42. 42 Celil AB, Hollinger JO, Campbell PG 2005 Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95: 518–528.
43. 43 Aghaloo T, Cowan C, Chou Y, Zhang X, Lee H, Miao S, Hong N, Kuroda S, Soo C, Wu B, Ting K 2006 Nell‐1 induced bone regeneration in calvarial defects. Am J Pathol 169: 903–915.